Special Drug Use Investigation for PAXIL Tablet (Long-term)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

339 participants

Study Classification

OBSERVATIONAL

Study Start Date

2001-05-31

Study Completion Date

2005-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This surveillance study is designed to detect adverse events (particularly clinically significant adverse drug reactions) occurring in clinical settings and to examine factors likely to affect the safety and efficacy of paroxetine in long-term use (1 year).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Drug Use Investigation for PAXIL Tablet

NCT01371435

Mental Disorders

COMPLETED

Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)

NCT01371461

Mental Disorders

COMPLETED

Combination Of PAXIL Tablet And Benzodiazepines

NCT00259883

Mental Disorders

COMPLETED PHASE4

Major Depressive Disorder Study In Adults

NCT00049972

Major Depressive Disorder

COMPLETED PHASE4

A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria

NCT00516113

Premenstrual Dysphoric Disorder Premenstrual Syndrome

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mental Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients prescribed PAXIL for long-term use

Patients with depression/depressed state or panic disorder prescribed PAXIL during study period

Paroxetine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paroxetine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with depression/depressed state or panic disorder
* PAXIL must be used for long-term

Exclusion Criteria

* Patients who had been taking PAXIL since before the start of the survey
* Patients with hypersensitivity to paroxetine
* Patients taking monoamine oxidase inhibitors (MAOIs) or within 2 weeks of stopping treatment with MAOIs
* Concomitant use in patients taking pimozide

Eligible Sex

ALL

Accepts Healthy Volunteers

No